C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
12/2009
12/01/2009	US7625497 Providing solutions containing selected concentrations of soluble orienting compounds in an isotropic phase or in a lyotropic liquid-crystalline phase, introducing solutions into template having at least one dimension that is micro- or nanoscaled, removing sufficient solvent to form anisotropic solid
11/2009
11/26/2009	WO2009141387A1 Quinoid rylene dicarboximides as ir absorbers
11/26/2009	WO2009120774A3 Method of preparing huperzine a and derivatives thereof
11/24/2009	US7622580 Colorant compounds
11/24/2009	CA2510177C Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
11/24/2009	CA2433197C Gyrase inhibitors and uses thereof
11/19/2009	CA2724214A1 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
11/18/2009	EP2119702A1 Amide derivative
11/18/2009	EP2118065A1 Novel substituted 1h-benz ýde¨isoquinoline-1, 3 -diones
11/18/2009	EP1615893B1 2-azabicyclo¬3.3.1 nonane derivatives as opioid receptor antagonists
11/18/2009	CN101580490A 3-azabicyclo (3.3.1) nonane-9-substituted derivative and preparation method thereof
11/17/2009	US7619086 HIV integrase inhibitors
11/17/2009	US7618967 Indane compounds
11/17/2009	CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/17/2009	CA2407094C Diazabicyclic central nervous system active agents
11/12/2009	US20090281135 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression
11/12/2009	US20090278118 Benzofluoranthene compound and organic light-emitting device using the compound
11/12/2009	DE102008022221A1 Inhibitoren der humanen Aldosteronsynthase CYP11B2 Inhibitors of human aldosterone synthase CYP11B2
11/11/2009	EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009	EP1477186B1 Antipruritics
11/11/2009	CN101578101A Sinomenine derivatives and preparation and uses thereof
11/11/2009	CN101575316A Method for separating and preparing 2-hydroxyl-1-methoxy aporphine from lotus leaves
11/11/2009	CN101575315A New naphthalimide derivative, preparation method and application thereof
11/11/2009	CN100558722C A method for the preparation of enantiomerically pure mirtazapine
11/11/2009	CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009	CA2320244C Method for producing aqueous polymer dispersions containing colorants
11/05/2009	US20090275523 Spirocyclic nitriles as protease inhibitors
11/05/2009	US20090274656 Hepatitis c virus inhibitors
11/04/2009	EP2113506A2 Salts of clopidogrel and process for preparation
11/04/2009	CN101573333A Inhibitors of histone deacetylase
11/03/2009	US7612085 N-(9-(6-aminohexyl)-9-azabicyclo[3.3.1]nonan-3 alpha-yl)-N'-(2-methoxy-5-methylphenyl)carbamate or corresponding 9-(p-dimethylaminobenzyl) compound, and a (m-bromophenyl)ethyl-nortropane compound; probes to the sigma 2 receptor; anticancer agents, antitumor agents, use with other chemotherapeutic agents
11/03/2009	CA2360767C Tricyclic benzodiazepines as vasopressin receptor antagonists
10/2009
10/29/2009	US20090270624 Process for purifying noroxymorphone compounds
10/29/2009	US20090270593 Nucleic acid binding substance containing catalytic nucleation nanoparticles
10/28/2009	EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009	CN101565435A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
10/28/2009	CN101565402A Indeno isoquinolone compound and preparation method and medical application thereof
10/27/2009	US7608714 Production of dolasetron
10/27/2009	US7608626 2-(3-ethyl-2-phenylindolizin-1-yl)ethylamine; 2-(1,2,3,4-tetrahydropyrido[1,2-a]indol-10-yl)ethylamine; 2-(1,2,3,4-tetrahydropyrido[1,2-a]indol-10-yl)ethylamine; agonists of the 2C subtype of brain serotonin receptors; useful to treat a variety of central nervous system disorders such as schizophrenia
10/27/2009	CA2437006C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/27/2009	CA2406044C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/27/2009	CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/22/2009	US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009	US20090260686 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/22/2009	CA2721203A1 Inhibitors of protein phosphatase-1 and uses thereof
10/21/2009	CN101560186A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/20/2009	US7605263 Fluorescent naphthalene-1,4,5,8-tetracarboxylic bisimides with an electron-donating substituent on the nucleus
10/20/2009	US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009	US7605111 Herbicides
10/20/2009	CA2376497C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
10/15/2009	US20090259045 Process for production of azabicycloalkanol derivative
10/15/2009	US20090258897 Substituted benzimidazoles
10/15/2009	US20090258871 Aza-Substituted Spiro Derivatives
10/15/2009	US20090258858 Muscarinic acetylcholine receptor antagonists
10/15/2009	US20090258857 Chemical compounds
10/14/2009	CN101555227A Preparation method of high purity bulleyaconitine A
10/14/2009	CN100549011C Novel imidazopyridines as cyclin dependent kinase inhibitors
10/08/2009	US20090253731 Method of identifying therapeutic agents
10/07/2009	CN101550167A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/07/2009	CN101550104A Benzene-naphthalene diimide derivative, preparation method and its application
10/06/2009	US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/06/2009	US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009	US7598242 Compounds for the treatment of inflammatory disorders
10/01/2009	WO2009120774A2 Method of preparing huperzine a and derivatives thereof
10/01/2009	WO2009119086A1 Method for producing 9-hydroxymethyl-cyclohepta[b]pyridine-3-carboxylate ester derivative
10/01/2009	WO2009118382A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
10/01/2009	US20090247754 Method of preparing huperzine a and derivatives thereof
10/01/2009	US20090247753 Acenaphthopyridine Derivative, Material of Light-Emitting Element, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance
10/01/2009	CA2716726A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
09/2009
09/30/2009	EP1768667B1 Cannabinoid receptor ligands
09/30/2009	EP1282732B1 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
09/30/2009	CN101544604A Tricyclic compounds
09/29/2009	US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009	CA2328280C Thienopyrimidines
09/29/2009	CA2293433C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors
09/24/2009	US20090239894 Stabilized aqueous solutions of ergoline compounds
09/24/2009	US20090238760 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same
09/24/2009	US20090235467 methyl 2-methyl-1-aminoindolizine-3-carboxylate, for example; use for dyeing keratin fibers, including human keratin fibers such as the hair
09/23/2009	EP2103665A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/23/2009	CN101541754A Azabicyclic compounds as inhibitors of monoamines reuptake
09/23/2009	CN101538290A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/22/2009	US7592453 Fused quinoline derivative and use thereof
09/22/2009	US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/22/2009	CA2209640C Cycloalkano-pyridines
09/16/2009	EP1828184B1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
09/16/2009	EP1363629B1 Kappa opioid receptor ligands
09/16/2009	CN101535269A Anthrapyridone compounds
09/16/2009	CN101535268A Tyrosine kinase inhibitors
09/16/2009	CN101531634A High-purity blonanserin and preparation method thereof
09/15/2009	CA2522323C 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands
09/15/2009	CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole]
09/11/2009	WO2009111337A1 Compounds and compositions as tlr activity modulators
09/11/2009	CA2716706A1 Compounds and compositions as tlr activity modulators
09/10/2009	US20090227613 Novel 3-Aza-Spiro[5.5]Undecane Derivatives and Their Use As Monoamine Neurotransmitter Re-Uptake Inhibitors
09/09/2009	EP1539753B1 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
09/09/2009	EP1519724B1 Fredericamycin derivatives as medicaments for treating tumours
09/09/2009	CN101528704A Serine-threonine protein kinase and PARP modulators
09/09/2009	CN100537542C Farnesyl protein transferase inhibitors as antitumor agents
09/08/2009	US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
09/08/2009	US7585872 Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors

1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 110